Reinventing Relevance: Five Levers for MedTech OEMs in the Era of Decentralized Diagnostics
Competing in this new landscape will require pragmatic approach, beyond mergers, acquisitions, startup acceleration, or technology additions. It calls for a rethinking of how these companies operate, how they create, deliver, and sustain value in a system that’s no longer centred on the lab. Part 1 of this article discussed a business hypothesis and a […]
Decentralization Dilemma – Why Diagnostic OEMs Must Redefine Relevance?
HPV Self-Sampling & Diagnostic Decentralization Business Hypothesis: As self-sampling and decentralized screening become mainstream, diagnostic value will migrate from centralized assay throughput to distributed patient participation. Traditional OEM business models, which rely on reagent volume, lab automation, and service lock-ins, continue to face the risk of economic erosion unless they redefine how and where they […]